Ajinomoto logo

Ajinomoto

Last updated January 31, 2026
72
Innovation Areas
1,635
Inventors
14
Collaborations

Amino acid protein glycation inhibitors: AjinomotoRecent Research Landscape

Accumulation of advanced glycation end-products causes structural skin degradation and hyperpigmentation. Specific D-amino acid isomers are engineered into formulations to competitively inhibit protein cross-linking and preserve tissue elasticity.

What technical problems is Ajinomoto addressing in Amino acid protein glycation inhibitors?

Follicular protein glycation damage

(8)evidences

Non-enzymatic glycosylation causes structural degradation and functional impairment of biological proteins. Preventing this damage mitigates tissue aging and hyperpigmentation disorders.

Age related musculoskeletal functional decline

(3)evidences

Poor absorption and chemical instability of essential compounds limit therapeutic efficacy. Enhancing solubility and structural stability ensures effective delivery and physiological uptake.